Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 10-Apr-24 5:15 PM View:  | Tierney David S Director | Catalyst Pharmaceutical Par... (CPRX) | 08-Apr-24 | Option Sale | 25,000 | $15.68 | $392,000.00 | (7%) 373.87K to 348.87K | |
| 10-Apr-24 5:15 PM View: | Tierney David S Director | Catalyst Pharmaceutical Par... (CPRX) | 08-Apr-24 | Option Exercise | 25,000 | $4.01 | $100,250.00 | 7% 348.87K to 373.87K | |
| 28-Mar-24 4:45 PM View: | Elsbernd Brian Chief Compliance/Legal Officer | Catalyst Pharmaceutical Par... (CPRX) | 27-Mar-24 | Private Sale | 25,000 | $16.44 | $411,000.00 | (17%) 149.43K to 124.43K | |
| 16-Feb-24 5:00 PM View: | Sundaram Preethi Chief Strategy Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Payment of Exercise | 6,025 | -- | -- | (19%) 31.57K to 25.54K | |
| 16-Feb-24 5:01 PM View: | Daly Richard J President and CEO Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 4,000 | -- | -- | 2% 209.33K to 213.33K | |
| 16-Feb-24 5:00 PM View: | Sundaram Preethi Chief Strategy Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 16,667 | -- | -- | 112% 14.9K to 31.57K | |
| 16-Feb-24 5:01 PM View: | Del Carmen Jeffrey Chief Commercial Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Payment of Exercise | 3,125 | -- | -- | (11%) 29.09K to 25.97K | |
| 16-Feb-24 5:01 PM View: | Denkhaus Donald A Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 4,000 | -- | -- | < 1% 434.33K to 438.33K | |
| 16-Feb-24 5:00 PM View: | Ingenito Gary Chief Med. & Reg. Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Payment of Exercise | 2,435 | -- | -- | (5%) 53.83K to 51.39K | |
| 16-Feb-24 5:00 PM View: | Elsbernd Brian Chief Compliance/Legal Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Payment of Exercise | 2,353 | -- | -- | (2%) 151.79K to 149.43K | |
| 16-Feb-24 5:01 PM View: | Tierney David S Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 4,000 | -- | -- | 1% 344.87K to 348.87K | |
| 16-Feb-24 5:00 PM View: | O'Keeffe Charles B Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 4,000 | -- | -- | < 1% 681.72K to 685.72K | |
| 16-Feb-24 5:01 PM View: | Del Carmen Jeffrey Chief Commercial Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 10,667 | -- | -- | 58% 18.43K to 29.09K | |
| 16-Feb-24 5:00 PM View: | Harper Molly Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 4,000 | -- | -- | 300% 1.33K to 5.33K | |
| 16-Feb-24 5:00 PM View: | Miller Steve Chief Op. & Scientific Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 13,667 | -- | -- | 2% 811.46K to 825.12K | |
| 16-Feb-24 5:00 PM View: | Ingenito Gary Chief Med. & Reg. Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 10,000 | -- | -- | 23% 43.83K to 53.83K | |
| 16-Feb-24 5:00 PM View: | Elsbernd Brian Chief Compliance/Legal Officer | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Option Exercise | 9,667 | -- | -- | 7% 142.12K to 151.79K | |
| 16-Feb-24 5:01 PM View: | Daly Richard J President and CEO Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Feb-24 | Payment of Exercise | 1,186 | -- | -- | (< 1%) 213.33K to 212.15K | |
| 06-Feb-24 5:00 PM View: | Denkhaus Donald A Director | Catalyst Pharmaceutical Par... (CPRX) | 05-Feb-24 | Option Exercise | 40,000 | $4.01 | $160,400.00 | 10% 394.33K to 434.33K | |
| 31-Jan-24 5:01 PM View: | McEnany Patrick J Director | Catalyst Pharmaceutical Par... (CPRX) | 30-Jan-24 | Option Exercise | 143,000 | -- | -- | 3% 4.39M to 4.53M | |
| 03-Jan-24 5:18 PM View: | O'Keeffe Charles B Director | Catalyst Pharmaceutical Par... (CPRX) | 02-Jan-24 | Option Exercise | 60,000 | $1.13 | $67,800.00 | 10% 621.72K to 681.72K | |
| 03-Jan-24 5:19 PM View: | McEnany Patrick J Director | Catalyst Pharmaceutical Par... (CPRX) | 02-Jan-24 | Option Exercise | 250,000 | $1.13 | $282,500.00 | 6% 4.14M to 4.39M | |
| 03-Jan-24 5:19 PM View: | Tierney David S Director | Catalyst Pharmaceutical Par... (CPRX) | 02-Jan-24 | Option Exercise | 10,000 | $1.13 | $11,300.00 | 3% 334.87K to 344.87K | |
| 29-Dec-23 5:00 PM View: | O'Keeffe Charles B Director | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 1,333 | -- | -- | < 1% 620.39K to 621.72K | |
| 29-Dec-23 5:00 PM View: | Del Carmen Jeffrey Chief Commercial Officer | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 8,666 | -- | -- | 64% 13.6K to 22.27K | |
| 29-Dec-23 5:00 PM View: | Miller Steve Chief Op. & Scientific Officer | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 14,000 | -- | -- | 2% 797.46K to 811.46K | |
| 29-Dec-23 5:00 PM View: | Ingenito Gary Chief Med. & Reg. Officer | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Payment of Exercise | 3,541 | -- | -- | (7%) 47.37K to 43.83K | |
| 29-Dec-23 5:00 PM View: | Elsbernd Brian Chief Compliance/Legal Officer | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 6,666 | -- | -- | 5% 138.08K to 144.74K | |
| 29-Dec-23 5:00 PM View: | McEnany Patrick J President and CEO Director | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Payment of Exercise | 10,362 | -- | -- | (< 1%) 4.15M to 4.14M | |
| 29-Dec-23 5:00 PM View: | Sundaram Preethi Chief Strategy Officer | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Payment of Exercise | 2,409 | -- | -- | (14%) 17.31K to 14.9K | |
| 29-Dec-23 5:00 PM View: | Grande Alicia VP, Treasurer and CFO | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Payment of Exercise | 3,410 | -- | -- | (6%) 59.22K to 55.81K | |
| 29-Dec-23 5:00 PM View: | Grande Alicia VP, Treasurer and CFO | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 8,666 | -- | -- | 17% 50.56K to 59.22K | |
| 29-Dec-23 5:00 PM View: | Tierney David S Director | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 1,333 | -- | -- | < 1% 333.54K to 334.87K | |
| 29-Dec-23 5:00 PM View: | McEnany Patrick J President and CEO Director | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 26,333 | -- | -- | < 1% 4.12M to 4.15M | |
| 29-Dec-23 5:00 PM View: | Daly Richard J Director | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 1,333 | -- | -- | < 1% 208.0K to 209.33K | |
| 29-Dec-23 5:00 PM View: | Sundaram Preethi Chief Strategy Officer | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 6,666 | -- | -- | 63% 10.64K to 17.31K | |
| 29-Dec-23 5:00 PM View: | Del Carmen Jeffrey Chief Commercial Officer | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Payment of Exercise | 3,839 | -- | -- | (17%) 22.27K to 18.43K | |
| 29-Dec-23 5:00 PM View: | Harper Molly Director | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 1,333 | -- | -- | 100% 0 to 1.33K | |
| 29-Dec-23 5:00 PM View: | Ingenito Gary Chief Med. & Reg. Officer | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 9,000 | -- | -- | 23% 38.37K to 47.37K | |
| 29-Dec-23 5:00 PM View: | Denkhaus Donald A Director | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Option Exercise | 1,333 | -- | -- | < 1% 393.0K to 394.33K | |
| 29-Dec-23 5:00 PM View: | Elsbernd Brian Chief Compliance/Legal Officer | Catalyst Pharmaceutical Par... (CPRX) | 27-Dec-23 | Payment of Exercise | 2,623 | -- | -- | (2%) 144.74K to 142.12K | |
| 19-Dec-23 5:00 PM View: | Harper Molly Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Dec-23 | Option Sale | 10,000 | $14.39 | $143,871.00 | (71%) 14.0K to 4.0K | |
| 19-Dec-23 5:00 PM View: | Harper Molly Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Dec-23 | Option Exercise | 10,000 | $5.78 | $57,800.00 | 250% 4.0K to 14.0K | |
| 19-Dec-23 5:00 PM View: | Harper Molly Director | Catalyst Pharmaceutical Par... (CPRX) | 15-Dec-23 | Sale | 4,000 | $14.39 | $57,548.60 | (100%) 4.0K to 0 | |
| 14-Dec-23 5:00 PM View: | Tierney David S Director | Catalyst Pharmaceutical Par... (CPRX) | 12-Dec-23 | Option Exercise | 50,000 | $1.13 | $56,500.00 | 15% 333.54K to 383.54K | |
| 14-Dec-23 5:00 PM View: | Tierney David S Director | Catalyst Pharmaceutical Par... (CPRX) | 12-Dec-23 | Option Sale | 50,000 | $13.32 | $666,250.00 | (13%) 383.54K to 333.54K | |
| 12-Dec-23 5:00 PM View: | Grande Alicia VP, Treasurer and CFO | Catalyst Pharmaceutical Par... (CPRX) | 11-Dec-23 | Option Exercise | 60,000 | $1.13 | $67,800.00 | 119% 50.56K to 110.56K | |
| 12-Dec-23 5:00 PM View: | Grande Alicia VP, Treasurer and CFO | Catalyst Pharmaceutical Par... (CPRX) | 11-Dec-23 | Option Sale | 60,000 | $13.76 | $825,780.00 | (54%) 110.56K to 50.56K | |
| 13-Dec-23 5:00 PM View: | Miller Steve Chief Op. & Scientific Officer | Catalyst Pharmaceutical Par... (CPRX) | 11-Dec-23 | Option Exercise | 150,000 | $1.13 | $169,500.00 | 23% 647.46K to 797.46K | |
| 12-Dec-23 5:00 PM View: | Grande Alicia VP, Treasurer and CFO | Catalyst Pharmaceutical Par... (CPRX) | 08-Dec-23 | Option Exercise | 40,000 | $1.13 | $45,200.00 | 79% 50.56K to 90.56K |
